Linda K. Han

Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

Steven M. Rowe, Cori Daines, Felix C. Ringshausen et al. · New England Journal of Medicine · 2017 · 499 citations · Full text

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

Lori J. Goldstein, Raymond P. Perez, Denise A. Yardley et al. · Breast Cancer Research · 2020 · 133 citations · Full text

Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial

Richard E. Fine, Richard C. Gilmore, Jill R. Dietz et al. · Annals of Surgical Oncology · 2021 · 116 citations

Surgical Oncology, Breast Oncology, Medicine +8

Comparative Evaluation of [99mTc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials

Anne M. Wallace, Linda K. Han, Stephen P. Povoski et al. · Annals of Surgical Oncology · 2013 · 110 citations · Full text

A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes

Sheldon Feldman, Savitri Krishnamurthy, William E. Gillanders et al. · Cancer · 2011 · 87 citations · Full text